Case Control Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Apr 27, 2023; 15(4): 621-633
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.621
Table 1 Clinicopathological characteristics of patients
All
Preoperative
Preoperative
P value
Preoperative
Preoperative
P value
n = 131
Low PMI, n = 36
High PMI, n = 95
High IMAC, n = 17
Low IMAC, n = 114
Age, yr64 (44-78)63 (50-75)65 (44-78)0.74968 (44-74)64 (45-78)0.034
Gender (male/female)120/1128/892/30.00115/2105/90.635
Preoperative body mass index21.4 (14.7-27.7)19.9 (14.7-24.2)21.6 (15.9-27.7)0.00121.6 (18.4-25.6)21.2 (14.7-27.7)0.194
PS ≥ 112 (9.2%)4 (11.1%)8 (8.4%)0.7361 (5.9%)16 (9.6%)0.708
ASA-PS (2/3)112/1930/682/130.78214/398/160.713
Albumin (g/dL)4.1 (2.9-4.9)3.9 (3.1-4.8)4.1 (2.9-4.9)0.1274.0 (3.5-4.5)4.1 (2.9-4.9)0.471
CRP (mg/dL)0.11 (0.01-7.37)0.11 (0.02-7.37)0.11 (0.01-6.48)0.9050.16 (0.20-4.53)0.10 (0.01-7.37)0.160
Neutrophil-lymphocyte ratio1.66 (0.24-22.33)2.10 (0.29-14.06)1.54 (0.24-22.33)0.2931.95 (0.59-7.73)1.54 (0.24-22.33)0.171
Prognostic nutritional index49.05 (35.70-106.15)46.65 (35.70-68.00)49.30 (37.30-106.15)0.09848.40 (40.75-53.35)49.33 (35.70-106.15)0.135
mGPS (0/1/2)105/21/527/8/178/13/40.51512/5/093/16/50.232
GNRI105.9 (81.7-121.4)99.0 (86.8-108.8)107.2 (81.7-121.4)0.001106.1 (86.1-121.4)105.4 (97.3-111.6)0.356
Clinical T-stage (1/2/3/4)3/68/57/31/14/20/12/54/37/20.3901/6/10/02/62/47/30.090
Clinical N-stage (0/1/2/3)51/35/36/913/11/9/338/24/27/60.8897/5/3/244/30/33/70.735
Clinical stage (II/III)68/6318/1850/450.84610/758/560.609
Tumor response to chemotherapy
CR/PR/SD/PD2/79/42/80/21/13/22/58/29/60.8520/6/9/22/73/33/60.090
Pre NAC PMI4.94 (2.40-8.86)3.66 (2.40-4.43)5.39 (3.34-8.86)0.0014.76 (3.28-6.64)5.01 (2.40-8.86)0.558
Pre NAC IMAC-0.46 (-1.07--0.19)-0.47 (-1.07--0.28)-0.46 (-1.06--0.19)0.248-0.32 (-0.75--0.19)-0.48 (-1.07--0.33)0.001
Operative time (min)443 (328-882)444 (328-882)443 (339-786)0.495452 (328-882)440 (350-786)0.472
Intraoperative bleeding (mL)730 (150-3015)652 (330-2550)732 (150-3015)0.258750 (450-2550)718 (150-3015)0.247
Postoperative complications (C-D ≥ 3)
Any complication53 (40.5%)16 (44.4%)37 (38.9%)0.6905 (29.4%)48 (42.1%)0.430
Respiratory complication28 (21.4%)8 (22.2%)20 (21.1%)1.0004 (23.5%)24 (21.1%)1.000
Anastomotic leakage3 (2.3%)2 (5.6%)1 (1.1%)0.1830 (0%)3 (2.6%)1.000
Pathological tumor grading
G1/G2/G3/Gx14/77/38/23/24/8/111/53/30/10.5341/9/7/013/68/31/20.600
pT-Stage (0/1/2/3/4)7/27/21/73/31/7/5/21/16/19/16/52/20.9850/2/4/11/07/25/17/62/30.796
pN-Stage (0/1/2/3)46/17/30/3811/8/11/635/9/19/320.0593/2/5/743/15/25/310.399
pStage (0/1/2/3)4/18/36/730/6/10/204/12/26/530.6400/2/2/134/16/34/600.279
Reoperation4 (3.1%)1 (2.8%)3 (3.2%)1.0000 (0%)4 (3.5%)0.651
Length of hospital stay (d)18 (11-225)18 (11-225)18 (11-112)0.63020 (11-225)18 (11-112)0.432
30 d mortality00000
90 d mortality00000
Harvested number of LNs91 (42-194)102 (44-194)90 (42-184)0.36082 (49-130)91 (42-194)0.092